The brain renin-angiotensin system: a diversity of functions and implications for CNS diseases (Q38005611)

26 August 2017

The brain renin-angiotensin system: a diversity of functions and implications for CNS diseases (English)

1 reference

26 August 2017

John W Wright

1

1 reference

PubMed ID

22535332

26 August 2017

Joseph W Harding

series ordinal

2

1 reference

26 August 2017

26 April 2012

1 reference

26 August 2017

1 reference

26 August 2017

465

1 reference

26 August 2017

1

1 reference

26 August 2017

133-151

1 reference

https://scigraph.springernature.com/pub.10.1007/s00424-012-1102-2

26 August 2017

0 references

cites work

Accelerated adhesion of grafted skin by laser-induced stress wave-based gene transfer of hepatocyte growth factor

1 reference

https://api.crossref.org/works/10.1007%2FS00424-012-1102-2

Hepatocyte growth factor as an enhancer of nmda currents and synaptic plasticity in the hippocampus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00424-012-1102-2

Effect of I.C.V. injection of AT4 receptor ligands, NLE1-angiotensin IV and LVV-hemorphin 7, on spatial learning in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00424-012-1102-2

Identification and development of specific inhibitors for insulin-regulated aminopeptidase as a new class of cognitive enhancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00424-012-1102-2

Alzheimer's, angiotensin IV and an aminopeptidase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00424-012-1102-2

Gene knockout of insulin-regulated aminopeptidase: loss of the specific binding site for angiotensin IV and age-related deficit in spatial memory

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00424-012-1102-2

Evidence that the angiotensin IV (AT(4)) receptor is the enzyme insulin-regulated aminopeptidase.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00424-012-1102-2

Identification and characterization of a new cognitive enhancer based on inhibition of insulin-regulated aminopeptidase.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00424-012-1102-2

AT4 receptor is insulin-regulated membrane aminopeptidase: potential mechanisms of memory enhancement

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00424-012-1102-2

Therapeutic targeting of insulin-regulated aminopeptidase: heads and tails?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00424-012-1102-2

Attenuation of scopolamine-induced learning deficits by LVV-hemorphin-7 in rats in the passive avoidance and water maze paradigms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00424-012-1102-2

Excitatory action of angiotensins II and IV on hippocampal neuronal activity in urethane anesthetized rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00424-012-1102-2

Review: AT1-receptors in the central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00424-012-1102-2

Ligands to the (IRAP)/AT4 receptor encompassing a 4-hydroxydiphenylmethane scaffold replacing Tyr2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00424-012-1102-2

Small potent ligands to the insulin-regulated aminopeptidase (IRAP)/AT(4) receptor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00424-012-1102-2

Hepatocyte growth factor (HGF) modulates GABAergic inhibition and seizure susceptibility.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00424-012-1102-2

Local renin-angiotensin system and the brain--a continuous quest for knowledge

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00424-012-1102-2

Brain aminopeptidases and hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00424-012-1102-2

Protective effect of the inhibition of the renin-angiotensin system on aging

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00424-012-1102-2

Facilitation of hippocampal synaptogenesis and spatial memory by C-terminal truncated Nle1-angiotensin IV analogs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00424-012-1102-2

D2 dopamine receptor blockade prevents cognitive effects of Ang IV and des-Phe6 Ang IV.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00424-012-1102-2

Dopamine D4 receptor antagonist L745,870 abolishes cognitive effects of intracerebroventricular angiotensin IV and des-Phe(6)-Ang IV in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00424-012-1102-2

Participation of D 1-4 dopamine receptors in the pro-cognitive effects of angiotensin IV and des-Phe 6 angiotensin IV.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00424-012-1102-2

CGP 42112A antagonism of the angiotensin II and angiotensin II(3-7) facilitation of recall in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00424-012-1102-2

Angiotensin II-(3-8)-hexapeptide affects motor activity, performance of passive avoidance and a conditioned avoidance response in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00424-012-1102-2

Cognitive effects attributed to angiotensin II may result from its conversion to angiotensin IV.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00424-012-1102-2

Effect of D(3) dopamine receptors blockade on the cognitive effects of angiotensin IV in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00424-012-1102-2

The 3-7 fragment of angiotensin II is probably responsible for its psychoactive properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00424-012-1102-2

Angiotensin II AT(1) receptor blockade selectively enhances brain AT(2) receptor expression, and abolishes the cold-restraint stress-induced increase in tyrosine hydroxylase mRNA in the locus coeruleus of spontaneously hypertensive rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00424-012-1102-2

Anteroventral third ventricle site of action for angiotensin induced thirst

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00424-012-1102-2

Ventricular obstruction: effect on drinking induced by intracranial injection of angiotensin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00424-012-1102-2

Angiotensin-induced thirst: effects of third ventricle obstruction and periventricular ablation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00424-012-1102-2

Sodium appetite decreased by central angiotensin blockade

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00424-012-1102-2

A new look at the renin-angiotensin system--focusing on the vascular system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00424-012-1102-2

Distribution of angiotensin IV binding sites (AT4 receptor) in the human forebrain, midbrain and pons as visualised by in vitro receptor autoradiography.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00424-012-1102-2

The angiotensin IV/AT4 receptor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00424-012-1102-2

Development of cognitive enhancers based on inhibition of insulin-regulated aminopeptidase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00424-012-1102-2

Effect of candesartan on prevention (DIRECT-Prevent 1) and progression (DIRECT-Protect 1) of retinopathy in type 1 diabetes: randomised, placebo-controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00424-012-1102-2

Candesartan suppresses chronic renal inflammation by a novel antioxidant action independent of AT1R blockade

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00424-012-1102-2

Effects of irbesartan on intracellular antioxidant enzyme expression and activity in adolescents and young adults with early diabetic angiopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00424-012-1102-2

Drug development of MET inhibitors: targeting oncogene addiction and expedience

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00424-012-1102-2

Hepatocyte growth factor regulation: an integral part of why wounds become chronic.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00424-012-1102-2

The renin-angiotensin system in the brain: possible therapeutic implications for AT(1)-receptor blockers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00424-012-1102-2

Angiotensin as neuromodulator/neurotransmitter in central control of body fluid and electrolyte homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00424-012-1102-2

Functions of angiotensin peptides in the rostral ventrolateral medulla.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00424-012-1102-2

Alan [corrected] N. Epstein award: Intracellular signaling and ingestive behaviors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00424-012-1102-2

Divergent behavioral roles of angiotensin receptor intracellular signaling cascades

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00424-012-1102-2

Angiotensin II receptor signalling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00424-012-1102-2

Protective effects of intranasal losartan in the APP/PS1 transgenic mouse model of Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00424-012-1102-2

Angiotensin II receptors and drug discovery in cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00424-012-1102-2

Hepatocyte growth factor attenuates cerebral ischemia-induced learning dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00424-012-1102-2

Hepatocyte growth factor improved learning and memory dysfunction of microsphere-embolized rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00424-012-1102-2

AT4 receptor activation increases intracellular calcium influx and induces a non-N-methyl-D-aspartate dependent form of long-term potentiation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00424-012-1102-2

Ang II and Ang IV: unraveling the mechanism of action on synaptic plasticity, memory, and epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00424-012-1102-2

Angiotensin IV and LVV-haemorphin 7 enhance spatial working memory in rats: effects on hippocampal glucose levels and blood flow

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00424-012-1102-2

Involvement of the AT1 receptor subtype in the effects of angiotensin IV and LVV-haemorphin 7 on hippocampal neurotransmitter levels and spatial working memory

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00424-012-1102-2

Proposed update of angiotensin receptor nomenclature.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00424-012-1102-2

Angiotensin IV displays only low affinity for native insulin-regulated aminopeptidase (IRAP).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00424-012-1102-2

Binding of "AT4 receptor" ligands to insulin regulated aminopeptidase (IRAP) in intact Chinese hamster ovary cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00424-012-1102-2

Angiotensin AT4 receptor ligand interaction with cystinyl aminopeptidase and aminopeptidase N: [125I]Angiotensin IV only binds to the cystinyl aminopeptidase apo-enzyme.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00424-012-1102-2

Brain angiotensin peptides regulate sympathetic tone and blood pressure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00424-012-1102-2

Antihypertensive treatments, cognitive decline, and dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00424-012-1102-2

Expression of insulin-responsive glucose transporter GLUT4 mRNA in the rat brain and spinal cord: an in situ hybridization study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00424-012-1102-2

Immunocytochemical localization of the insulin-responsive glucose transporter 4 (Glut4) in the rat central nervous system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00424-012-1102-2

The effects of commonly prescribed drugs in patients with Alzheimer's disease on the rate of deterioration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00424-012-1102-2

Drinking induced by injection of angiotensin into the rain of the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00424-012-1102-2

The insulin-regulated aminopeptidase IRAP is colocalised with GLUT4 in the mouse hippocampus--potential role in modulation of glucose uptake in neurones?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00424-012-1102-2

Distribution and cellular localization of insulin-regulated aminopeptidase in the rat central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00424-012-1102-2

Sub-cellular localization of insulin-regulated membrane aminopeptidase, IRAP to vesicles in neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00424-012-1102-2

Novel angiotensin peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00424-012-1102-2

The effect on drinking of peptide precursors and of shorter chain peptide fragments of angiotensin II injected into the rat's diencephalon.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00424-012-1102-2

Cerebroprotection mediated by angiotensin II: a hypothesis supported by recent randomized clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00424-012-1102-2

Prevention of dementia by antihypertensive drugs: how AT1-receptor-blockers and dihydropyridines better prevent dementia in hypertensive patients than thiazides and ACE-inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00424-012-1102-2

Renin-angiotensin system revisited

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00424-012-1102-2

Pathophysiological basis of migraine prophylaxis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00424-012-1102-2

Renin activity in brain tissue of puppies and adult dogs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00424-012-1102-2

The role of angiotensin II in cognition and behaviour

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00424-012-1102-2

Angiotensin as a target for the treatment of Alzheimer's disease, anxiety and depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00424-012-1102-2

Physiological and pathological aspects of Abeta in iron homeostasis via 5'UTR in the APP mRNA and the therapeutic use of iron-chelators

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00424-012-1102-2

Angiotensin IV stimulates plasminogen activator inhibitor-1 expression in proximal tubular epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00424-012-1102-2

Angiotensin type 1 receptor antagonist losartan, reduces MPTP-induced degeneration of dopaminergic neurons in substantia nigra.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00424-012-1102-2

Angiotensin II protects against alpha-synuclein toxicity and reduces protein aggregation in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00424-012-1102-2

Evidence for the efficacy of ARBs across the cardiovascular continuum

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00424-012-1102-2

HGF regulates the development of cortical pyramidal dendrites

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00424-012-1102-2

Antihypertensive agents for aging patients who are at risk for cognitive dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00424-012-1102-2

A role for the angiotensin IV/AT4 system in mediating natriuresis in the rat

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00424-012-1102-2

Role of AT1 receptors in the central control of sympathetic vasomotor function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00424-012-1102-2

Renin-angiotensin system blockade and cardiovascular and renal protection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00424-012-1102-2

Hepatocyte growth factor, its receptor, and their potential value in cancer therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00424-012-1102-2

The cerebral ventricles as the avenue for the dipsogenic action of intracranial angiotensin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00424-012-1102-2

Enzymatic pathways of the brain renin-angiotensin system: unsolved problems and continuing challenges.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00424-012-1102-2

Development of angiotensin IV analogs as hepatocyte growth factor/Met modifiers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00424-012-1102-2

Interleukin-9 induces tyrosine phosphorylation of insulin receptor substrate-1 via JAK tyrosine kinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00424-012-1102-2

Angiotensin induction of PAI-1 expression in endothelial cells is mediated by the hexapeptide angiotensin IV

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00424-012-1102-2

Antihypertensive medication use and incident Alzheimer disease: the Cache County Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00424-012-1102-2

Expression of c-Met in developing rat hippocampus: evidence for HGF as a neurotrophic factor for calbindin D-expressing neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00424-012-1102-2

The effects of angiotensin IV analogs on long-term potentiation within the CA1 region of the hippocampus in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00424-012-1102-2

Angiotensin II- and IV-induced changes in cerebral blood flow. Roles of AT1, AT2, and AT4 receptor subtypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00424-012-1102-2

Next generation multifunctional angiotensin receptor blockers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00424-012-1102-2

Potentiation of cholinergic transmission in the rat hippocampus by angiotensin IV and LVV-hemorphin-7.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00424-012-1102-2

Structure-activity study of LVV-hemorphin-7: angiotensin AT4 receptor ligand and inhibitor of insulin-regulated aminopeptidase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00424-012-1102-2

Angiotensin AT4 ligands are potent, competitive inhibitors of insulin regulated aminopeptidase (IRAP).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00424-012-1102-2

Activation of multiple signaling modules is critical in angiotensin IV-induced lung endothelial cell proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00424-012-1102-2

Neuritogenic activity of chondroitin/dermatan sulfate hybrid chains of embryonic pig brain and their mimicry from shark liver. Involvement of the pleiotrophin and hepatocyte growth factor signaling pathways.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00424-012-1102-2

Angiotensin converting enzyme inhibitors reduce alcohol consumption: some possible mechanisms and important conditions for its therapeutic use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00424-012-1102-2

Jacques Benoit lecture: the neuroendocrine view of the angiotensin and apelin systems.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00424-012-1102-2

Organisation and functional role of the brain angiotensin system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00424-012-1102-2

Chronic production of angiotensin IV in the brain leads to hypertension that is reversible with an angiotensin II AT1 receptor antagonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00424-012-1102-2

The replacement of His(4) in angiotensin IV by conformationally constrained residues provides highly potent and selective analogues

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00424-012-1102-2

Conformational constraints in angiotensin IV to probe the role of Tyr², Pro⁵ and Phe⁶.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00424-012-1102-2

c-Met: structure, functions and potential for therapeutic inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00424-012-1102-2

The renin-angiotensin systems: evolving pharmacological perspectives for cerebroprotection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00424-012-1102-2

The role of the brain renin-angiotensin system in hypertension: implications for new treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00424-012-1102-2

Captopril as an antidepressant? Effects on the learned helplessness paradigm in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00424-012-1102-2

Loss of embryonic MET signaling alters profiles of hippocampal interneurons.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00424-012-1102-2

Expression of placental leucine aminopeptidase/oxytocinase in neuronal cells and its action on neuronal peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00424-012-1102-2

Haploinsufficiency of c-Met in cd44-/- mice identifies a collaboration of CD44 and c-Met in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00424-012-1102-2

ACE-I and ARBs in early diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00424-012-1102-2

The brain renin-angiotensin system: location and physiological roles.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00424-012-1102-2

Water intake and the neural correlates of the consciousness of thirst

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00424-012-1102-2

Effects of extracellular matrix-degrading proteases matrix metalloproteinases 3 and 9 on spatial learning and synaptic plasticity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00424-012-1102-2

Effects of matrix metalloproteinase inhibition on short- and long-term plasticity of schaffer collateral/CA1 synapses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00424-012-1102-2

Proteases involved in the metabolism of angiotensin II, bradykinin, calcitonin gene-related peptide (CGRP), and neuropeptide Y by vascular smooth muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00424-012-1102-2

The role of the central renin-angiotensin system in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00424-012-1102-2

The cytoplasmic tail of the T cell receptor zeta chain is required for signaling via CD26.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00424-012-1102-2

Protection of hippocampal neurons from ischemia-induced delayed neuronal death by hepatocyte growth factor: a novel neurotrophic factor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00424-012-1102-2

Angiotensin IV inhibits neurite outgrowth in cultured embryonic chicken sympathetic neurones.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00424-012-1102-2

Effects of angiotensin II receptor blockers on dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00424-012-1102-2

Stress sensitivity is increased in transgenic rats with low brain angiotensinogen

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00424-012-1102-2

Reduction of dopaminergic degeneration and oxidative stress by inhibition of angiotensin converting enzyme in a MPTP model of parkinsonism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00424-012-1102-2

Brain angiotensin and circulatory control

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00424-012-1102-2

Bioactive angiotensin peptides: focus on angiotensin IV.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00424-012-1102-2

Myocardial protection from ischemia/reperfusion injury by endogenous and exogenous HGF.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00424-012-1102-2

Angiotensin IV Reverses the Acute Cerebral Blood Flow Reduction after Experimental Subarachnoid Hemorrhage in the Rat

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00424-012-1102-2

Norleucine1-Angiotensin IV alleviates mecamylamine-induced spatial memory deficits

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00424-012-1102-2

Neural mechanisms of angiotensin II-salt hypertension: implications for therapies targeting neural control of the splanchnic circulation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00424-012-1102-2

A CRYSTALLINE PRESSOR SUBSTANCE (ANGIOTONIN) RESULTING FROM THE REACTION BETWEEN RENIN AND RENIN-ACTIVATOR

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00424-012-1102-2

Physiology of local renin-angiotensin systems.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00424-012-1102-2

Peripherally administered angiotensin II AT1 receptor antagonists are anti-stress compounds in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00424-012-1102-2

A role for the angiotensin AT4 receptor subtype in overcoming scopolamine-induced spatial memory deficits

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00424-012-1102-2

Angiotensin III modulates the nociceptive control mediated by the periaqueductal gray matter

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00424-012-1102-2

Functions of angiotensin in the central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00424-012-1102-2

Specific angiotensin II receptive neurons in the cat subfornical organ

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00424-012-1102-2

Brain renin angiotensin in disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00424-012-1102-2

Angiotensin II in central nervous system physiology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00424-012-1102-2

Differential regulation of thalamic and cortical axonal growth by hepatocyte growth factor/scatter factor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00424-012-1102-2

Involvement of angiotensin II and angiotensin IV in producing the individual characteristics of defensive and feeding behavior in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00424-012-1102-2

The renin-angiotensin system: peptides and enzymes beyond angiotensin II

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00424-012-1102-2

Inhibition of aminopeptidases by amastatin and bestatin derivatives. Effect of inhibitor structure on slow-binding processes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00424-012-1102-2

Human placental leucine aminopeptidase/oxytocinase. A new member of type II membrane-spanning zinc metallopeptidase family

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00424-012-1102-2

The angiotensin AT2 receptor in inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00424-012-1102-2

Characterization of the insulin-regulated membrane aminopeptidase in 3T3-L1 adipocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00424-012-1102-2

Brain angiotensin II: new developments, unanswered questions and therapeutic opportunities

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00424-012-1102-2

Dependence of adrenalectomy-induced sodium appetite on the action of angiotensin II in the brain of the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00424-012-1102-2

Glutamate controls growth rate and branching of dopaminergic axons

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00424-012-1102-2

Does use of antihypertensive drugs affect the incidence or progression of dementia? A systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00424-012-1102-2

Hepatocyte growth factor in synaptic plasticity and Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00424-012-1102-2

Gene transfer of hepatocyte growth factor gene improves learning and memory in the chronic stage of cerebral infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00424-012-1102-2

Subfornical organ: site of drinking elicitation by angiotensin II.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00424-012-1102-2

Comparing angiotensin II receptor blockers on benefits beyond blood pressure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00424-012-1102-2

The preparation, purification, and amino acid sequence of a polypeptide renin substrate

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00424-012-1102-2

The significance of brain aminopeptidases in the regulation of the actions of angiotensin peptides in the brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00424-012-1102-2

The evolving story of the RAAS in hypertension, diabetes and CV disease: moving from macrovascular to microvascular targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00424-012-1102-2

Involvement of the somatostatin-2 receptor in the anti-convulsant effect of angiotensin IV against pilocarpine-induced limbic seizures in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00424-012-1102-2

Involvement of insulin-regulated aminopeptidase in the effects of the renin-angiotensin fragment angiotensin IV: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00424-012-1102-2

Involvement of insulin-regulated aminopeptidase and/or aminopeptidase N in the angiotensin IV-induced effect on dopamine release in the striatum of the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00424-012-1102-2

Metabolism of angiotensin II is required for its in vivo effect on dopamine release in the striatum of the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00424-012-1102-2

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00424-012-1102-2

Effects of discrete kainic acid-induced hippocampal lesions on spatial and contextual learning and memory in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00424-012-1102-2

Discovery of a distinct binding site for angiotensin II (3-8), a putative angiotensin IV receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00424-012-1102-2

Intraventricular administration of hepatocyte growth factor treats mouse communicating hydrocephalus induced by transforming growth factor beta1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00424-012-1102-2

[Ischemic brain injury and hepatocyte growth factor].

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00424-012-1102-2

Alleviation of Abeta-induced cognitive impairment by ultrasound-mediated gene transfer of HGF in a mouse model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00424-012-1102-2

Angiotensin peptides modulatory system: how is it implicated in the control of seizure susceptibility?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00424-012-1102-2

Effects of angiotensin III and angiotensin IV on pentylenetetrazol seizure susceptibility (threshold and kindling): interaction with adenosine A(1) receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00424-012-1102-2

The effects of sarmesin, an Angiotensin II analogue on seizure susceptibility, memory retention and nociception

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00424-012-1102-2

The expression of mRNAs for hepatocyte growth factor/scatter factor, its receptor c-met, and one of its activators tissue-type plasminogen activator show a systematic relationship in the developing and adult cerebral cortex and hippocampus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00424-012-1102-2

Angiotensin receptors: form and function and distribution

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00424-012-1102-2

Drinking and arterial blood pressure responses to ANG II in young and old rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00424-012-1102-2

Central effects of angiotensins on drinking and blood pressure: structure-activity relationships.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00424-012-1102-2

Increased hepatocyte growth factor level in cerebrospinal fluid in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00424-012-1102-2

Cognitive deficit in amyloid-beta-injected mice was improved by pretreatment with a low dose of telmisartan partly because of peroxisome proliferator-activated receptor-gamma activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00424-012-1102-2

Hepatocyte growth factor reduces the infarct volume after transient focal cerebral ischemia in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00424-012-1102-2

Hepatocyte growth factor-induced enhancement of dendritic branching is blocked by inhibitors of N-methyl-D-aspartate receptors and calcium/calmodulin-dependent kinases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00424-012-1102-2

The receptor tyrosine kinase Met and its ligand hepatocyte growth factor are clustered at excitatory synapses and can enhance clustering of synaptic proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00424-012-1102-2

Signaling by hepatocyte growth factor in neurons is induced by pharmacological stimulation of synaptic activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00424-012-1102-2

The role of the renin-angiotensin-aldosterone system in heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00424-012-1102-2

Differential effects of central angiotensin II and substance P on sympathetic nerve activity in conscious rats. Implications for cardiovascular adaptation to behavioral responses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00424-012-1102-2

Natriuretic action of central angiotensin II in conscious rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00424-012-1102-2

From angiotensin IV binding site to AT4 receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00424-012-1102-2

Angiotensin and vascular fibrinolytic balance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00424-012-1102-2

Cellular targets for angiotensin II fragments: pharmacological and molecular evidence.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00424-012-1102-2

Angiotensin IV in the central nervous system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00424-012-1102-2

Opposite effects of angiotensin II and IV in the lateral nucleus of the amygdala.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00424-012-1102-2

The CNS renin-angiotensin system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00424-012-1102-2

Vasopressin is a physiological substrate for the insulin-regulated aminopeptidase IRAP.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00424-012-1102-2

Valsartan lowers brain beta-amyloid protein levels and improves spatial learning in a mouse model of Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00424-012-1102-2

Nonhypotensive dose of telmisartan attenuates cognitive impairment partially due to peroxisome proliferator-activated receptor-gamma activation in mice with chronic cerebral hypoperfusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00424-012-1102-2

Angiotensin IV enhances LTP in rat dentate gyrus in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00424-012-1102-2

Roles of brain angiotensins II and III in thirst and sodium appetite.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00424-012-1102-2

Clinical trials of the past decade in the management of chronic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00424-012-1102-2

Effects of LY231617 and angiotensin IV on ischemia-induced deficits in circular water maze and passive avoidance performance in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00424-012-1102-2

The brain angiotensin system and extracellular matrix molecules in neural plasticity, learning, and memory

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00424-012-1102-2

The brain RAS and Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00424-012-1102-2

Brain renin-angiotensin--a new look at an old system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00424-012-1102-2

Extracellular matrix molecules, long-term potentiation, memory consolidation and the brain angiotensin system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00424-012-1102-2

Angiotensin II(3-8) (ANG IV) hippocampal binding: potential role in the facilitation of memory.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00424-012-1102-2

Conversion of brain angiotensin II to angiotensin III is critical for pressor response in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00424-012-1102-2

Angiotensin receptor subtype mediated physiologies and behaviors: new discoveries and clinical targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00424-012-1102-2

Cross talk between c-Met and epidermal growth factor receptor during retinal pigment epithelial wound healing

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00424-012-1102-2

The angiotensin IV analog Nle-Tyr-Leu-psi-(CH2-NH2)3-4-His-Pro-Phe (norleual) can act as a hepatocyte growth factor/c-Met inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00424-012-1102-2

Brain and peripheral angiotensin II type 1 receptors mediate renal vasoconstrictor and blood pressure responses to angiotensin IV in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00424-012-1102-2

Renal vasoconstrictor and pressor responses to angiotensin IV in mice are AT1a-receptor mediated.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00424-012-1102-2

Identification of antihypertensive drugs which inhibit amyloid-beta protein oligomerization

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00424-012-1102-2

Identification of metabolic pathways of brain angiotensin II and III using specific aminopeptidase inhibitors: predominant role of angiotensin III in the control of vasopressin release

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00424-012-1102-2

Biochemistry and pharmacology of the renin-angiotensin system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00424-012-1102-2

Angiotensin converting enzyme inhibitors: animal experiments suggest a new pharmacological treatment for alcohol abuse in humans

21 January 2018

1 reference

12 December 2020

The major protein of GLUT4-containing vesicles, gp160, has aminopeptidase activity

1 reference

12 December 2020

Forebrain sites of action for drinking and salt appetite to angiotensin or captopril

1 reference

12 December 2020

Angiotensin IV Activates the Nuclear Transcription Factor-κB and Related Proinflammatory Genes in Vascular Smooth Muscle Cells

1 reference

12 December 2020

Effects of mesenchymal stem cells transfected with human hepatocyte growth factor gene on healing of burn wounds.

1 reference

12 December 2020

Mimics of the dimerization domain of hepatocyte growth factor exhibit anti-Met and anticancer activity

1 reference

12 December 2020

Brain angiotensinergic activity: the state of our current knowledge.

1 reference

12 December 2020

Cerebroventricular sites for enkephalin inhibition of the central actions of angiotensin

1 reference

12 December 2020

Identification of an AII(3-8) [AIV] binding site in guinea pig hippocampus.

1 reference

12 December 2020

Brain renin-angiotensin system in cognitive function: pre-clinical findings and implications for prevention and treatment of dementia.

1 reference

12 December 2020

Adenosine-angiotensin II interactions in pentylenetetrazol seizure threshold in mice

1 reference

12 December 2020

1 reference

12 December 2020

Structure-function analyses of brain angiotensin control of pressor action in rats

1 reference

12 December 2020

Cloning and characterization of a novel insulin-regulated membrane aminopeptidase from Glut4 vesicles

1 reference

12 December 2020

Strong neurogenesis, angiogenesis, synaptogenesis, and antifibrosis of hepatocyte growth factor in rats brain after transient middle cerebral artery occlusion

1 reference

12 December 2020

Chronic peripheral administration of the angiotensin II AT(1) receptor antagonist candesartan blocks brain AT(1) receptors

1 reference

12 December 2020

Cerebroprotective effect of angiotensin IV in experimental ischemic stroke in the rat mediated by AT(4) receptors.

1 reference

12 December 2020

Angiotensin IV receptors and signaling in opossum kidney cells

1 reference

12 December 2020

A rat brain isozyme of angiotensin-converting enzyme. Unique specificity for amidated peptide substrates.

1 reference

12 December 2020

Angiotensin, thirst, and sodium appetite

1 reference

12 December 2020

Potentiated angiogenic effect of scatter factor/hepatocyte growth factor via induction of vascular endothelial growth factor: the case for paracrine amplification of angiogenesis

1 reference

12 December 2020

Evidence of a possible role of altered angiotensin function in the treatment, but not etiology, of depression

1 reference

12 December 2020

Angiotensin and captopril increase alcohol intake.

1 reference

12 December 2020

Regulatory role of brain angiotensins in the control of physiological and behavioral responses

1 reference

12 December 2020

Synthesis and pharmacology of the octapeptide angiotonin

1 reference

12 December 2020

Characterization and signaling of the AT(4) receptor in human proximal tubule epithelial (HK-2) cells

1 reference

12 December 2020

The production of serous effusions in nephrectomised animals by the administration of renal extracts and renin

1 reference

12 December 2020

Aminopeptidase A antiserum inhibits intracerebroventricular angiotensin II-induced dipsogenic and pressor responses

1 reference

12 December 2020

Structural determinants for the activation mechanism of the angiotensin II type 1 receptor differ for phosphoinositide hydrolysis and mitogen-activated protein kinase pathways

1 reference

12 December 2020

Synthesis and biological activities of analogues of angiotensins II and III containing O-methyltyrosine and D-tryptophan

1 reference

12 December 2020

Therapeutic angiogenesis induced by human recombinant hepatocyte growth factor in rabbit hind limb ischemia model as cytokine supplement therapy

1 reference

12 December 2020

Cognitive-enhancing effects of angiotensin IV

1 reference

12 December 2020

Angiotensin II binding to mammalian brain membranes

1 reference

12 December 2020

The substance causing renal hypertension

1 reference

12 December 2020

Ang II and Ang III modulate PTZ seizure threshold in non-stressed and stressed mice: possible involvement of noradrenergic mechanism

1 reference

12 December 2020

Interference with central actions of angiotensin II suppresses sodium appetite

1 reference

12 December 2020

Possible contribution of brain angiotensin III to ingestive behaviors in baboons.

1 reference

12 December 2020

The kidney and thirst regulation

1 reference

12 December 2020

Functional studies of nonpeptide angiotensin II receptor subtype-specific ligands: DuP 753 (AII-1) and PD123177 (AII-2).

1 reference

12 December 2020

Aminopeptidase N/CD13 is directly linked to signal transduction pathways in monocytes

1 reference

12 December 2020

International union of pharmacology. XXIII. The angiotensin II receptors

1 reference

12 December 2020

The molecular and clinical impact of hepatocyte growth factor, its receptor, activators, and inhibitors in wound healing

1 reference

12 December 2020

Characterization of AT4 receptor from bovine aortic endothelium with photosensitive analogues of angiotensin IV

1 reference

12 December 2020

Important role for angiotensin III and IV in the brain renin-angiotensin system

1 reference

12 December 2020

1 reference

12 December 2020

Contributions of the brain angiotensin IV-AT4 receptor subtype system to spatial learning.

1 reference

12 December 2020

Franz Volhard Lecture. Renin-angiotensin system: a dual tissue and hormonal system for cardiovascular control

1 reference

12 December 2020

Insulin stimulates cell surface aminopeptidase activity toward vasopressin in adipocytes

1 reference

12 December 2020

Brain and Pituitary Angiotensin

1 reference

12 December 2020

The angiotensin converting enzyme (ACE) inhibitor, perindopril, modifies the clinical features of Parkinson's disease

1 reference

12 December 2020

Sodium appetite during captopril blockade of endogenous angiotensin II formation.

1 reference

12 December 2020

Endothelial dysfunction: A potential therapeutic target for geriatric depression and brain amyloid deposition in Alzheimer's disease?

1 reference

12 December 2020

Hypertension during chronic peripheral and central infusion of angiotensin III.

1 reference

12 December 2020

Differential inhibition of aminopeptidase A and aminopeptidase N by new beta-amino thiols

1 reference

12 December 2020

Mineralocorticoids and cerebral angiotensin may act together to produce sodium appetite

1 reference

12 December 2020

Expression of hepatocyte growth factor in primary sensory neurons of adult rats

1 reference

12 December 2020

Increased sodium appetite in the rat induced by intracranial administration of components of the renin-angiotensin system

1 reference

12 December 2020

Effect of hepatocyte growth factor on gene expression of extracellular matrix during wound healing of the injured rat vocal fold

1 reference

12 December 2020

Characterization and function of the bovine kidney epithelial angiotensin receptor subtype 4 using angiotensin IV and divalinal angiotensin IV as receptor ligands

1 reference

12 December 2020

Angiotensin receptor blockers for the reduction of proteinuria in diabetic patients with overt nephropathy: results from the AMADEO study.

1 reference

12 December 2020

Dynamics of calcium and its roles in the dendrite of the cerebellar Purkinje cell.

1 reference

12 December 2020

Angiotensin III and IV activation of the brain AT1 receptor subtype in cardiovascular function

1 reference

12 December 2020

Hemorphins inhibit angiotensin IV binding and interact with aminopeptidase N

1 reference

12 December 2020

Mechanism of action of norepinephrine in eliciting an eating response on injection into the rat hypothalamus.

1 reference

12 December 2020

Angiotensin stimulation of the central nervous system

1 reference

12 December 2020

Brain angiotensin: pathways and pharmacology

1 reference

12 December 2020

Pressor action and dipsogenicity induced by angiotensin II and III in rats.

1 reference

12 December 2020

Synthesis and properties of angiotonin

1 reference

12 December 2020

Angiotensin IV induces tyrosine phosphorylation of focal adhesion kinase and paxillin in proximal tubule cells

1 reference

12 December 2020

The angiotensin hexapeptide 3-8 fragment potently inhibits [125I]angiotensin II binding to non-AT1 or -AT2 recognition sites in bovine adrenal cortex

1 reference

12 December 2020

10.1007/S00424-012-1102-2

Identifiers

DOI

1 reference

PubMed ID

22535332

Dimensions Publication ID

26 August 2017

0 references

1 reference

PubMed ID

22535332